References
- Joshi S , PeckAB, KhanSR. NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys. Oxid. Med. Cell. Longev.2013, 462361 (2013).
- Pizzino G , IrreraN, CucinottaMet al. Oxidative stress: harms and benefits for human health. Oxid. Med. Cell. Longev.2017, 8416763 (2017).
- Brito R , CastilloG, GonzalezJ, VallsN, RodrigoR. Oxidative stress in hypertension: mechanisms and therapeutic opportunities. Exp. Clin. Endocrinol. Diabetes123(6), 325–335 (2015).
- Chabrashvili T , TojoA, OnozatoMLet al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension39(2), 269–274 (2002).
- Welch WJ , BlauJ, XieH, ChabrashviliT, WilcoxCS. Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am. J. Physiol. Heart. Circ. Physiol.288(1), H22–H28 (2005).
- Cifuentes-Pagano E , MeijlesDN, PaganoPJ. The quest for selective Nox inhibitors and therapeutics: challenges, triumphs and pitfalls. Antioxid. Redox. Signal.20(17), 2741–2754 (2014).
- Joshi S , WangW, PeckAB, KhanSR. Activation of the NLRP3 inflammasome in association with calcium oxalate crystal induced reactive oxygen species in kidneys. J. Urol.193(5), 1684–1691 (2015).
- Joshi S , WangW, KhanSR. Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: inflammatory changes are mainly associated with crystal deposition. PLoS ONE12(11), e0185009 (2017).
- Anders HJ , Suarez-AlvarezB, GrigorescuMet al. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury. Kidney Int.93(3), 656–669 (2018).
- Li Y , PaganoPJ. Microvascular NADPH oxidase in health and disease. Free Radic. Biol. Med.109, 33–47 (2017).
- Sui Y , TianR, LuN. NADPH oxidase is a primary target for antioxidant effects by inorganic nitrite in lipopolysaccharide-induced oxidative stress in mice and in macrophage cells. Nitric Oxide89, 46–53 (2019).
- Sharma M , KaurT, SinglaSK. Role of mitochondria and NADPH oxidase derived reactive oxygen species in hyperoxaluria induced nephrolithiasis: therapeutic intervention with combinatorial therapy of N-acetyl cysteine and apocynin. Mitochondrion27, 15–24 (2016).
- Yousefian M , ShakourN, HosseinzadehHet al. The natural phenolic compounds as modulators of NADPH oxidases in hypertension. Phytomedicine55, 200–213 (2019).
- Mousslim M , PaganoA, AndreottiNet al. Peptide screen identifies a new NADPH oxidase inhibitor: impact on cell migration and invasion. Eur. J. Pharmacol.794, 162–172 (2017).
- Zhang J , YangS, LiH, ChenF, ShiJ. Naringin ameliorates diabetic nephropathy by inhibiting NADPH oxidase 4. Eur. J. Pharmacol.804, 1–6 (2017).
- Hirano K , ChenWS, ChuengAL, DunneAA, SeredeninaTet al. Discovery of GSK2795039, a novel small molecule NADPH oxidase 2 inhibitor. Antioxid. Redox. Signal.23(5), 358–374 (2015).
- Zhu W , ZhaoZ, ChouFJet al. The protective roles of estrogen receptor beta in renal calcium oxalate crystal formation via reducing the liver oxalate biosynthesis and renal oxidative stress-mediated cell injury. Oxid. Med. Cell. Longev.2019, 5305014 (2019).
- Lu J , RisboodP, KaneCT Jret al. Characterization of potent and selective iodonium-class inhibitors of NADPH oxidases. Biochem. Pharmacol.143, 25–38 (2017).
- Augsburger F , FilippovaA, RastiDet al. Pharmacological characterization of the seven human NOX isoforms and their inhibitors. Redox. Biol.26, 101272 (2019).
- Joshi S , KhanSR. Opportunities for future therapeutic interventions for hyperoxaluria: targeting oxidative stress. Expert. Opin. Ther. Targets23(5), 379–391 (2019).